- Home
- TONX vs ANVS Comparison
TONX vs ANVS Comparison
Compare TONX & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TONX | ANVS |
|---|---|---|
| Founded | N/A | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.5M | 111.3M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | TONX | ANVS |
|---|---|---|
| Price | $1.96 | $2.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $13.50 |
| AVG Volume (30 Days) | 493.0K | ★ 520.5K |
| Earning Date | 03-24-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 7.29 | N/A |
| Revenue | ★ $7,760,000.00 | N/A |
| Revenue This Year | $526.82 | N/A |
| Revenue Next Year | $45.45 | N/A |
| P/E Ratio | $0.27 | ★ N/A |
| Revenue Growth | ★ 3760.70 | N/A |
| 52 Week Low | $1.78 | $1.11 |
| 52 Week High | $29.77 | $5.50 |
Technical Indicators
Market Signals| Indicator | TONX | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 29.15 | 32.52 |
| Support Level | $1.78 | $2.42 |
| Resistance Level | $2.70 | $2.81 |
| Average True Range (ATR) | 0.22 | 0.20 |
| MACD | -0.09 | -0.04 |
| Stochastic Oscillator | 8.84 | 5.27 |
Price Performance
Historical ComparisonAbout TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.